Efficacy of clinical stage Ⅲ nasopharyngeal carcinoma treated by intensity-modulated radiation therapy combined with chemotherapy
LIANG Yi,LIN Shao-jun,PAN Jian-ji,HAN Lu,ZONG Jing-feng,QIU Su-fang,LIN Jin
2012-01-01
Abstract:Background and purpose:Intensity-modulated radiation therapy(IMRT) enables the delivery of higher radiation dose to the primary disease and neck metastases while sparing the organs/tissues at risk(OARs) thereby IMRT combined with chemotherapy enhancing the therapeutic ratio.How to further improve the efficacy became a common topic of the oncologists.Different stages of nasopharyngeal carcinoma(NPC) have different efficacy.The subgroups in the same stage whether have different efficacy still remain to be studied.This study retrospectively analyzed the outcome of clinical stage Ⅲ NPC patients treated with IMRT after induction chemotherapy with or without adjuvant chemotherapy.Methods:From Nov.2003 to Jun.2006,133 patients with untreated stage Ⅲ NPC were analyzed retrospectively.According to the AJCC 2002 staging system: 7(5.3%) patients were T3N0,39(29.3%) patients were T3N1,48(36.1%) patients were T2N2,39(29.3%) patients were T3N2.All the patients received IMRT.One hundred and twenty-four patients received induction chemotherapy.Twenty-four patients received concurrent chemotherapy.Thirty-three patients received adjuvant chemotherapy.Results:The 5-year local-regional free survival(LRFS),distant metastasis-free survival(DMFS),disease-free survival(DFS) and overall survival(OS) were 90.9%,89.9%,82.5%,and 83.4%.The 5-year LRFS,DMFS,DFS and OS of patients with T2,T3 disease were 93.1% vs 89.4%(χ2=0.407,P=0.524),91.2% vs 89.3%(χ2=0.152,P=0.697),86.5% vs 80.0%(χ2=0.899,P=0.343),81.1% vs 84.7%(χ2=0.311,P=0.577).The 5-year LRFS,DMFS,DFS and OS of patients with N0-1,N2 disease were 91.1% vs 90.9%(χ2=0.007,P=0.933),97.8% vs 85.8%(χ2=4.69,P=0.030),88.9% vs 79.2%(χ2=1.746,P=0.1836),93.5% vs 78.1%(χ2=5.052,P=0.025).Adjuvant chemotherapy provided no significant benefit to IMRT in stage Ⅲ NPC,but was responsible for higher rates of grade 3 or 4 toxicities(48% vs 27.6%,P<0.005).Conclusion:IMRT combined with chemotherapy is an effective treatment for patients diagnosed with stage Ⅲ NPC.Patients with N0-1 disease have a better OS and DMFS than patients with N2 disease.Further improving the effect of stage Ⅲ NPC still need to explore the significance of adjuvant chemotherapy and look for more effective chemotherapy drugs,targeted drugs and more reasonable combined treatments.